Literature DB >> 22880953

Effective treatment of pomalidomide in central nervous system myelomatosis.

Alberto Mussetti, Serena Dalto, Vittorio Montefusco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22880953     DOI： 10.3109/10428194.2012.718343

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

Review 1.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

2.  Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue.

Authors:  Yao Jiang; Jiang Wang; Darlene M Rozewski; Shamalatha Kolli; Chia-Hsien Wu; Ching-Shih Chen; Xiaoxia Yang; Craig C Hofmeister; John C Byrd; Amy J Johnson; Mitch A Phelps
Journal:  J Pharm Biomed Anal       Date:  2013-09-02       Impact factor: 3.935

3.  Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Authors:  Artur Jurczyszyn; Norbert Grzasko; Alessandro Gozzetti; Jacek Czepiel; Alfonso Cerase; Vania Hungria; Edvan Crusoe; Ana Luiza Miranda Silva Dias; Ravi Vij; Mark A Fiala; Jo Caers; Leo Rasche; Ajay K Nooka; Sagar Lonial; David H Vesole; Sandhya Philip; Shane Gangatharan; Agnieszka Druzd-Sitek; Jan Walewski; Alessandro Corso; Federica Cocito; Marie-Christine M Vekemans; Erden Atilla; Meral Beksac; Xavier Leleu; Julio Davila; Ashraf Badros; Ekta Aneja; Niels Abildgaard; Efstathios Kastritis; Dorotea Fantl; Natalia Schutz; Tomas Pika; Aleksandra Butrym; Magdalena Olszewska-Szopa; Lidia Usnarska-Zubkiewicz; Saad Z Usmani; Hareth Nahi; Chor S Chim; Chaim Shustik; Krzysztof Madry; Suzanne Lentzsch; Alina Swiderska; Grzegorz Helbig; Renata Guzicka-Kazimierczak; Nikoletta Lendvai; Anders Waage; Kristian T Andersen; Hirokazu Murakami; Sonja Zweegman; Jorge J Castillo
Journal:  Am J Hematol       Date:  2016-04-24       Impact factor: 10.047

4.  Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence.

Authors:  Muhammad Bilal Abid; Sanjay De Mel; Muhammad Abbas Abid; Kong Bing Tan; Wee Joo Chng
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

5.  Successful Intrathecal Chemotherapy Combined with Radiotherapy Followed by Pomalidomide and Low-Dose Dexamethasone Maintenance Therapy for a Primary Plasma Cell Leukemia Patient.

Authors:  Yusuke Yamashita; Shinobu Tamura; Takehiro Oiwa; Hiroshi Kobata; Kodai Kuriyama; Toshiki Mushino; Shogo Murata; Hiroki Hosoi; Akinori Nishikawa; Nobuyoshi Hanaoka; Takashi Sonoki
Journal:  Hematol Rep       Date:  2017-02-23

Review 6.  Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature.

Authors:  Gergely Varga; Gábor Mikala; László Gopcsa; Zoltán Csukly; Sarolta Kollai; György Balázs; Tímár Botond; Nikolett Wohner; Laura Horváth; Gergely Szombath; Péter Farkas; Tamás Masszi
Journal:  J Oncol       Date:  2018-04-23       Impact factor: 4.375

7.  Proptosis and hemiplegia as an initial manifestation of multiple myeloma.

Authors:  N Tahiliani; P Kataria; A Patel; P Kendre
Journal:  J Postgrad Med       Date:  2018 Oct-Dec       Impact factor: 1.476

8.  Successful eradication of leptomeningeal plasma cell disease.

Authors:  Øyvind Bruserud; Bent-Are Hansen; Nils Vetti; Silje Johansen; Håkon Reikvam
Journal:  Oxf Med Case Reports       Date:  2018-07-03

Review 9.  Multiple myeloma with central nervous system relapse.

Authors:  Philip A Egan; Patrick T Elder; W Ian Deighan; Sheila J M O'Connor; H Denis Alexander
Journal:  Haematologica       Date:  2020-05-15       Impact factor: 9.941

10.  Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial.

Authors:  Jason Fangusaro; Duane A Mitchell; Mehmet Kocak; Giles W Robinson; Patricia Ann Baxter; Eugene I Hwang; Jianping Huang; Arzu Onar-Thomas; Ira J Dunkel; Maryam Fouladi; Katherine E Warren
Journal:  Pediatr Blood Cancer       Date:  2020-10-07       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.